| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
1 Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie an der Universität Hamburg, Hamburg, Germany, and
2 Departement für Chemie und Biochemie, Universität Bern, Bern, Switzerland
Homeodomain-interacting protein kinase 2 (HIPK2) is a serine/threonine kinase involved in transcriptional regulation and apoptosis. Here we demonstrate that HIPK2 regulates transforming growth factor (TGF) ß-induced c-Jun NH2-terminal kinase (JNK) activation and apoptosis. HIPK2 colocalizes with Daxx, a protein acting in TGF-ß-induced JNK activation and apoptosis, in promyelocytic leukemia (PML) nuclear bodies, and triggers PML-nuclear body disruption and release of Daxx. HIPK2 interacts in vitro and in vivo via its kinase domain with Daxx, and a fraction of Daxx coprecipitates with HIPK2 under physiological conditions. Moreover, overexpression of HIPK2 leads to Daxx phosphorylation, and ectopic expression of HIPK2 activates the JNK signaling pathway, which is enhanced by coexpression of Daxx. HIPK2 signals to JNK via a pathway using Daxx and the mitogen-activated protein kinase kinases MKK4/SEK1 and MKK7. Ectopic expression of HIPK2 and Daxx potentiates TGF-ß-induced apoptosis in human p53-deficient hepatocellular carcinoma cells. Finally, we demonstrate that knockdown of endogenous HIPK2 using RNA interference inhibits TGF-ß-induced JNK activation and apoptosis. Taken together, our findings indicate that HIPK2 participates in the TGF-ß signaling pathway leading to JNK activation and apoptosis.
This article has been cited by other articles:
![]() |
N. Wethkamp and K.-H. Klempnauer Daxx Is a Transcriptional Repressor of CCAAT/Enhancer-binding Protein {beta} J. Biol. Chem., October 16, 2009; 284(42): 28783 - 28794. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Weidtkamp-Peters, T. Lenser, D. Negorev, N. Gerstner, T. G. Hofmann, G. Schwanitz, C. Hoischen, G. Maul, P. Dittrich, and P. Hemmerich Dynamics of component exchange at PML nuclear bodies J. Cell Sci., August 15, 2008; 121(16): 2731 - 2743. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-C. Lan, H.-J. Li, G. Lin, P.-Y. Lai, and B.-c. Chung Cyclic AMP Stimulates SF-1-Dependent CYP11A1 Expression through Homeodomain-Interacting Protein Kinase 3-Mediated Jun N-Terminal Kinase and c-Jun Phosphorylation Mol. Cell. Biol., March 15, 2007; 27(6): 2027 - 2036. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Dauth, J. Kruger, and T. G. Hofmann Homeodomain-Interacting Protein Kinase 2 Is the Ionizing Radiation-Activated p53 Serine 46 Kinase and Is Regulated by ATM Cancer Res., March 1, 2007; 67(5): 2274 - 2279. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Li, X. Wang, X. Wu, Y. Rui, W. Liu, J. Wang, X. Wang, Y.-C. Liou, Z. Ye, and S.-C. Lin Daxx Cooperates with the Axin/HIPK2/p53 Complex to Induce Cell Death Cancer Res., January 1, 2007; 67(1): 66 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Wang, M. Iordanov, and Q. Zhang c-Jun NH2-terminal Kinase Promotes Apoptosis by Down-regulating the Transcriptional Co-repressor CtBP J. Biol. Chem., November 17, 2006; 281(46): 34810 - 34815. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Muromoto, M. Ishida, K. Sugiyama, Y. Sekine, K. Oritani, K. Shimoda, and T. Matsuda Sumoylation of Daxx Regulates IFN-Induced Growth Suppression of B Lymphocytes and the Hormone Receptor-Mediated Transactivation J. Immunol., July 15, 2006; 177(2): 1160 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Castillo, E. Erroba, M. J. Perugorria, M. Santamaria, D. C. Lee, J. Prieto, M. A. Avila, and C. Berasain Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells. Cancer Res., June 15, 2006; 66(12): 6129 - 6138. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Isono, K. Nemoto, Y. Li, Y. Takada, R. Suzuki, M. Katsuki, A. Nakagawara, and H. Koseki Overlapping roles for homeodomain-interacting protein kinases hipk1 and hipk2 in the mediation of cell growth in response to morphogenetic and genotoxic signals. Mol. Cell. Biol., April 1, 2006; 26(7): 2758 - 2771. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D'Orazi, M. G. Sciulli, V. Di Stefano, S. Riccioni, M. Frattini, R. Falcioni, L. Bertario, A. Sacchi, and P. Patrignani Homeodomain-Interacting Protein Kinase-2 Restrains Cytosolic Phospholipase A2-Dependent Prostaglandin E2 Generation in Human Colorectal Cancer Cells Clin. Cancer Res., February 1, 2006; 12(3): 735 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Moustakas and C.-H. Heldin Non-Smad TGF-{beta} signals J. Cell Sci., August 15, 2005; 118(16): 3573 - 3584. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Hofmann, E. Jaffray, N. Stollberg, R. T. Hay, and H. Will Regulation of Homeodomain-interacting Protein Kinase 2 (HIPK2) Effector Function through Dynamic Small Ubiquitin-related Modifier-1 (SUMO-1) Modification J. Biol. Chem., August 12, 2005; 280(32): 29224 - 29232. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, A. Nottke, and R. H. Goodman Homeodomain-interacting protein kinase-2 mediates CtBP phosphorylation and degradation in UV-triggered apoptosis PNAS, February 22, 2005; 102(8): 2802 - 2807. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gostissa, M. Morelli, F. Mantovani, E. Guida, S. Piazza, L. Collavin, C. Brancolini, C. Schneider, and G. Del Sal The Transcriptional Repressor hDaxx Potentiates p53-dependent Apoptosis J. Biol. Chem., November 12, 2004; 279(46): 48013 - 48023. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |